The European platform for deploying safe and governed agentic workflows
in healthcare, Mindoo, has secured €5 million in seed financing from 6DC,
Syndicate One and a group of strategic angel investors.
Healthcare organisations are increasingly balancing limited staffing with
growing demand for care, leaving some workflows unfinished or not recorded
because teams do not have the capacity to manage them.
Mindoo addresses this by providing configurable AI agents that hospital
teams use to handle structured intake, documentation drafting, follow-up
interactions and front-desk communication within a single platform.
The company currently offers four core agents that hospitals can adapt to
their own protocols, languages, and speciality workflows: a receptionist agent
for routine patient communication and registration, a pre-visit agent for
structured intake and medical history, a scribe agent for drafting notes,
letters, and orders, and a follow-up agent for post-visit communication and
care pathways.
We learned very quickly that workflows in healthcare cannot be adapted
to a product. The product has to adapt to existing workflows. That is why
Mindoo lets hospital teams configure and run their own agents, so automation
fits naturally into how they already work,
explained Gauthier Willemse, CEO and co-founder of Mindoo.
Mindoo is currently
deployed in hospitals in Belgium and Germany and is designed to integrate with
modern EHR systems. The company plans to expand into the Netherlands and France
as additional reference sites become operational.
The investment
supports Mindoo’s plan to provide hospitals and practices with a scalable AI
workforce layer that can take on routine tasks, ease pressure on clinical
teams, and keep organisations in control of their workflows.
The
funding will be used to develop the platform further, bring its four core
agents to production readiness across multiple specialities, and expand the team
across engineering, clinical, and deployment functions.